Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene-guided NAC for prevention of anti-TB drug-induced hepatitis
NCT06484530Phase 4Recruiting
- Sponsor
- Mahidol University
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in hepatitis, sponsored by Mahidol University. Started Mar 2024; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
hepatitis
Beyond the preview
Go deeper on NCT06484530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06484530.